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Implication for health policy/practice/research/medical education:
The results of this study revealed that hydroalcoholic extract of P. oleracea seeds aggregates hypertension in dexamethasone-
induced hypertensive rats. Therefore, it is recommended that its using be avoided in hypertensive patients receiving glucocorticoids.
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Introduction: Portulaca oleracea is used as a nutritional and medicinal plant. The aim of this 
study was to assess the effect of hydroalcoholic extract of P. oleracea seeds in dexamethasone 
-induced hypertension in rats. 
Methods: For induction of hypertension, dexamethasone (30 µg/kg/d, subcutaneously) was 
administered for 14 days. Animals received P. oleracea extract as a pretreatment at various doses 
of 100, 200 and 400 mg/kg/d orally from 4 days before dexamethasone administration and 
during the test period. Systolic blood pressure (SBP) and heart rate were measured using tail-
cuff method. The weight of thymus gland was estimated as a marker of glucocorticoid activity. 
Results: Dexamethasone injection significantly increased SBP (P < 0.001) while decreased 
the body and thymus weights (P < 0.05 and P < 0.001, respectively). Oral administration of P. 
oleracea could not prevent rising in SBP and decreasing in thymus weight. It also increased heart 
rate in hypertensive rats at the dose of 400 mg/kg/d (P < 0.05). 
Conclusion: The results of this study revealed that hydroalcoholic extract of P. oleracea seeds 
aggregates hypertension in dexamethasone-induced hypertensive rats. Hence, it should be used 
with caution in hypertensive patients receiving glucocorticoids.
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Introduction 
Hypertension or high blood pressure is a common global 
health problem. According to the statistical report of the 
World Health Organization (WHO) in 2015, about 24.0% 
of male and 20.5% of female subjects suffer from high 
blood pressure worldwide. There is also a high prevalence 
of hypertension in Iran and this vascular disease affects 
24.1% of Iranian male and 23.3% of Iranian female subjects 
above 18 years old (1). Hypertension is an important cause 
for dangerous disorders in major end-organs such as 
ischemic heart diseases, stroke and renal failure (2). The 
early diagnosis of hypertension and its medical treatment 
along with a change in life style would be associated with 
a decline in the risk of cardiovascular events (3). However, 
high blood pressure is properly managed only in less than 
30% of patients and many people complain of side effects 
of conventional antihypertensive drugs (4). Recent studies 
have reported the preventive and helpful effects of various 
herbal medicines in cardiovascular diseases including 
hypertension (5).
Portulaca oleracea L. commonly known as purslane 
belongs to the Portulacea family. This annual succulent 
herb is growing throughout the Old World and used 
as a salad and vegetable in many countries (6). Wide 
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range of pharmacological properties has been reported 
for various extracts of P. oleracea including antioxidant, 
antibacterial, hepatoprotective, analgesic, muscle relaxant, 
anti-inflammatory, bronchodilatory, antihyperglycemic, 
antihyperlipidemic and anticancer activities (6-11). Some 
investigations have proposed the potential of this herbal 
medicine for protection against cardiovascular diseases 
(12).
In this study, an attempt was made to determine the 
effect of hydroalcoholic extract of P. oleracea seeds in 
dexamethasone-induced hypertension in rats.
Methods
Animals
Male Wistar rats weighing 180 to 220 g were randomly 
selected from the animal house of the School of Pharmacy 
and Pharmaceutical Sciences (Isfahan, Iran). The animals 
were kept under standard laboratory conditions including 
12 h light/12 h dark cycle and room temperature of 20-
25°C with free access to water and standard animal diet. 
Chemicals 
Captopril was purchased from Tehran Darou 
Pharmaceutical Co. (Tehran, Iran) and dexamethasone 
was obtained from Darou Pakhsh Pharmaceutical Co. 
(Tehran, Iran). 
Plant material and preparation of the extract
The P. oleracea seeds were purchased from a local market 
of medicinal plants in Isfahan, Iran, and authenticated by 
Dr Ghaemmaghami (Department of Biology, School of 
Science, University of Isfahan). A voucher specimen (No. 
1891) was deposited at the Herbarium of the School of 
Pharmacy and Pharmaceutical Sciences, Isfahan, Iran. For 
the preparation of hydroalcoholic extract, the powdered 
seeds of plant were extracted with ethanol (70%), using 
maceration method for 72 hours at room temperature. 
After completion of extraction (3 times), the solvent was 
removed by a rotary evaporator under low pressure at 
50ºC to yield a viscous residue. The obtained extract was 
stored at -20°C. 
Experimental design
For induction of hypertension, dexamethasone (30 µg/
kg/d) was injected subcutaneously (s.c.) in rats for 14 
days, and the control group received daily s.c. injection of 
normal saline (1 mL/kg). In this prevention study, animals 
received P. oleracea seeds extract (100, 200 and 400 mg/
kg) or captopril (40 mg/kg, an antihypertensive agent as 
a reference drug) orally using an intra-gastric tube from 
4 days before dexamethasone administration and during 
the test period (days 1-18). Six rats were used in each 
group. All animals were weighted on alternate days. At 
the end of the experiment, the rats were sacrificed under 
ether anesthesia and the thymus glands were isolated. 
The weight of thymus was measured and expressed as 
milligrams per 100 g body weight. Decline in thymus 
weight was considered as a marker of glucocorticoid 
activity (13,14).
Measurement of systolic blood pressure and heart rate
The systolic blood pressure (SBP) and heart rate were 
recorded by non-invasive tail-cuff method (AD Instrument 
PowerLab Data Acquisition System, Australia) at the first 
and last days of the experiment in conscious rats. Ten 
minutes before measurements, each animal was restrained 
in a heated chamber at 38±1°C. A training period of 1 
week was established before the experiment to allow the 
rats become adapted to the procedure. Five measurements 
of blood pressure and heart rate were taken for each rat 
and their averages were used to obtain the mean values.
Statistical analysis
All values were shown as the mean ± standard error of 
mean (SEM). For statistical evaluation, one-way analysis 
of variance (ANOVA) followed by Tukey post  hoc test 
was used (SPSS software version 18.0). Differences with a 
value of P < 0.05 were considered to be significant.
Results 
Effect of Portulaca oleracea seeds extract on blood pressure
Administration of dexamethasone significantly increased 
SBP from 116.3 ± 2.7 to 152.6 ± 3.6 mmHg (P < 0.001) 
compared to the normal control group (122. 5 ± 1.5 mm 
Hg). Captopril caused a significant decrease in SBP (P 
< 0.001) but pretreatment with P. oleracea seeds extract 
could not prevent the increase in SBP (Figure 1).
Effect of Portulaca oleracea seeds extract on heart rate
As shown in Figure 2, heart rate was not significantly 
changed after administration of dexamethasone, captopril 
or P. oleracea seeds extract at the doses of 100 and 200 
mg/kg. However, treatment with 400 mg/kg of P. oleracea 
seeds extract caused a significant increase in rats heart 
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Figure 1. Effects of P. oleracea seeds extract and captopril (40 
mg/kg) on systolic blood pressure in dexamethasone-induced 
hypertensive rats. Values are means ± SEM for six rats. ###P 
<0.001 versus normal saline group, and ***P < 0.001 versus 
dexamethasone group.
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rate compared to the normal control group (P < 0.05).
Effect of Portulaca oleracea seeds extract on body weight
Dexamethasone injection caused a significant decrease in 
body weight in hypertensive animals compared to normal 
control group (P < 0.05). Administration of P. oleracea 
seeds extract significantly increased weight loss at all 
doses. However, captopril could prevent body weight loss 
induced by dexamethasone (P < 0.05, Figure 3).
Effect of Portulaca oleracea on thymus weight
Administration of dexamethasone significantly reduced 
the thymus gland weight as a marker of glucocorticoid 
activity in hypertensive rats (P < 0.001). Treatment with P. 
Oleracea seeds extract and captopril could not prevent the 
thymus weight decline (Figure 4).
Discussion
The present study investigated the effect of hydroalcoholic 
extract of P. oleracea seeds on blood pressure in the animal 
model of dexamethasone-induced hypertension in rats. 
The results showed that oral administration of P. Oleracea 
seeds extract could not prevent rising in SBP. 
Chronic use of dexamethasone leads to hypertension 
through various mechanisms including increased activity 
of cardiovascular regulating systems such as sympathetic, 
renin-angiotensin and endothelin systems and changing 
in hemodynamic status (15). Augmented sensitivity 
and reactivity to angiotensin II and norepinephrine and 
subsequently increased vascular resistance have been 
defined following dexamethasone administration (16). 
The roles of oxidative stress and over-production of 
reactive oxygen species (ROS) through nicotinamide 
adenine dinucleotide phosphate (NAPDH) oxidase 
pathway and nitric oxide (NO) deficiency have also been 
implicated in the pathophysiology of glucocorticoid-
induced hypertension (17). Some antioxidant agents and 
herbal medicines have been able to prevent and reduce 
hypertension from dexamethasone in various investigations 
(18). The hydroalcoholic extract of stems and green leaves 
of P. oleracea has been reported to have antihypertensive 
activity with negative ionotropic and chronotropic effects 
(19). Phytochemical analysis of P. oleracea demonstrated 
the presence of flavonoids, terpenoids, coumarins, 
alkaloids, sterols and various nutrients including calcium, 
magnesium, thiamin, riboflavin, nicotinic acid, vitamin C, 
carotene, vitamin E, fatty acids, omega-3, linolenic acid, 
oxalic acid and others (20,21). Its aerial parts are also rich 
in potassium ions elucidating the muscle relaxant effect 
of P. oleracea (8). There are also valid documents for the 
presence of biologically active catecholamines including 
noradrenaline, dopamine and L-dopa in P. oleracea. 
Large concentrations of noradrenaline in the fresh plant 
have been reported as 2.5 mg/g which is probably larger 
than that of extractable amount from the mammalians 
suprarenal glands (22). These neurotransmitters may be 
responsible for increasing blood pressure in this model 
of hypertension in which dexamethasone intensifies the 
reactivity to vasopressor effects of catecholamines.
There is no accurate data for toxicity profile of seeds 
Figure 2. Effects of P. oleracea seeds extract and captopril (40 
mg/kg) on heart rate in dexamethasone-induced hypertensive 
rats. Values are means ± SEM for six rats. #P < 0.05 versus 
normal saline control group.
Figure 3. Effects of P. oleracea seeds extract and captopril (40 
mg/kg) on body weight in dexamethasone-induced hypertensive 
rats. Values are means ± SEM for six rats. #P < 0.05, ##P < 0.01 
and ###P < 0.001 versus normal saline control group and *P < 0.05 
versus dexamethasone group.
Figure 4. Effects of P. oleracea seeds extract and captopril (40 mg/
kg) on thymus weight in dexamethasone-induced hypertensive 
rats.  Values are means ± SEM for six rats. ###P < 0.001 versus 
normal saline control group
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of P. oleracea, however Musa and coworkers reported 
moderate toxicity and LD50 about 1853-1875 mg/kg for 
methanolic extract of P. oleracea (23). There are some 
reports for the alteration in oxalic acid content in P. 
oleracea extract based on the nitrogen concentration and 
nitrate/ammonium ratio in the nutrient solutions (24). 
Toxic level of plasma oxalate has been associated with 
atherogenic activity through increasing the intracellular 
calcium concentration in endothelial cells and inhibition 
of endothelial proliferation (25). Although P. oleracea 
extract at the dose of 400 mg/kg has been used in some 
studies (26), but it seems that the lower doses would have 
the better safety profile with minor adverse effects.
The results of the present study also showed increasing 
in weight loss after administration of P. oleracea seeds 
extract in dexamethasone-induced hypertensive rats. 
The hypolipidemic effect and reducing body weight 
gain have been reported for P. oleracea in animal models 
of hyperlipidemia. Different biochemicals such as 
polyphenols, phytosterols, alkaloids and saponins may 
be responsible for antihyperlipidemic effect of this plant 
through decreasing food intake, increasing gastrointestinal 
motility, promoting insulin sensitivity, regulating the cell 
energy metabolism or reducing free fatty acids, reducing 
cholesterol absorption through interfering with its 
enterohepatic circulation and increasing cholesterol fecal 
excretion (11,27).
Conclusion
The results of this study revealed that hydroalcoholic extract 
of P. oleracea seeds could not prevent dexamethasone-
induced hypertension. The presence of high amounts of 
catecholamines in this extract and increasing reactivity to 
vasopressor effects of catecholamines in dexamethasone-
induced hypertension may be accountable for increasing 
blood pressure in this animal model of hypertension. 
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